BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 11137867)

  • 1. The effects of glutamate receptor agonists on neurotensin release using in vivo microdialysis.
    Radke JM; Owens MJ; Nemeroff CB
    Eur J Pharmacol; 2001 Jan; 411(1-2):129-134. PubMed ID: 11137867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine release in the prefrontal cortex during stress is reduced by the local activation of glutamate receptors.
    Del Arco A; Mora F
    Brain Res Bull; 2001 Sep; 56(2):125-30. PubMed ID: 11704349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of excitatory amino acid modulation of dopamine release in the prefrontal cortex of conscious rats.
    Jedema HP; Moghddam B
    J Neurochem; 1996 Apr; 66(4):1448-53. PubMed ID: 8627297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NMDA- and MK801-induced changes in dopamine release are attenuated in kainic acid-lesioned nucleus accumbens of conscious rats: an in vivo microdialysis study.
    Yoshida M; Yokoo H; Mizoguchi K; Tanaka T; Emoto H; Tanaka M
    Brain Res; 1998 Mar; 786(1-2):226-9. PubMed ID: 9555028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of glutamate receptor agonist on extracellular glutamate dynamics during moderate cerebral ischemia.
    Kunimatsu T; Asai S; Kanematsu K; Kohno T; Misaki T; Ishikawa K
    Brain Res; 2001 Dec; 923(1-2):178-86. PubMed ID: 11743986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of dopamine D1- and NMDA receptors in regulating neurotensin release in the striatum and nucleus accumbens.
    Wagstaff JD; Gibb JW; Hanson GR
    Brain Res; 1997 Feb; 748(1-2):241-4. PubMed ID: 9067469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The noradrenaline-dopamine interaction in the rat medial prefrontal cortex studied by multi-probe microdialysis.
    Kawahara H; Kawahara Y; Westerink BH
    Eur J Pharmacol; 2001 Apr; 418(3):177-86. PubMed ID: 11343687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of N-methyl-D-aspartate receptors in dopamine D1-, but not D2-, mediated changes in striatal and accumbens neurotensin systems.
    Singh NA; Bush LG; Gibb JW; Hanson GR
    Brain Res; 1992 Feb; 571(2):260-4. PubMed ID: 1351780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine and GABA increases produced by activation of glutamate receptors in the nucleus accumbens are decreased during aging.
    Segovia G; Mora F
    Neurobiol Aging; 2005 Jan; 26(1):91-101. PubMed ID: 15585349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of striatal acetylcholine concentrations by NMDA and the competitive NMDA receptor-antagonist AP-5: an in vivo microdialysis study.
    Knauber J; Kischka U; Roth M; Schmidt WJ; Hennerici M; Fassbender K
    J Neural Transm (Vienna); 1999; 106(1):35-45. PubMed ID: 10195333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenosine receptor-mediated modulation of dopamine release in the nucleus accumbens depends on glutamate neurotransmission and N-methyl-D-aspartate receptor stimulation.
    Quarta D; Borycz J; Solinas M; Patkar K; Hockemeyer J; Ciruela F; Lluis C; Franco R; Woods AS; Goldberg SR; Ferré S
    J Neurochem; 2004 Nov; 91(4):873-80. PubMed ID: 15525341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Facilitation of GABA release by neurotensin is associated with a reduction of dopamine release in rat nucleus accumbens.
    Tanganelli S; O'Connor WT; Ferraro L; Bianchi C; Beani L; Ungerstedt U; Fuxe K
    Neuroscience; 1994 Jun; 60(3):649-57. PubMed ID: 7936192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of neuronal and glial activities in control of the extracellular d-serine concentrations by the AMPA glutamate receptor in the mouse medial prefrontal cortex.
    Ishiwata S; Umino A; Nishikawa T
    Neurochem Int; 2018 Oct; 119():120-125. PubMed ID: 28966065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stress-induced dopamine release in the neostriatum: evaluation of the role of action potentials in nigrostriatal dopamine neurons or local initiation by endogenous excitatory amino acids.
    Keefe KA; Sved AF; Zigmond MJ; Abercrombie ED
    J Neurochem; 1993 Nov; 61(5):1943-52. PubMed ID: 7901337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concentration-dependent dual action of locally applied N-methyl-D-aspartate on extracellular dopamine in the rat prefrontal cortex in vivo.
    Feenstra MG; van der Weij W; Botterblom MH
    Neurosci Lett; 1995 Dec; 201(2):175-8. PubMed ID: 8848246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Participation of NMDA and kainate receptors of paraventricular nucleus in cardiovascular responses to glutamate receptor agonist.
    Gören MZ; Onat F; Berkman K
    Eur J Pharmacol; 2000 Jan; 388(1):77-84. PubMed ID: 10657549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurotensin modulation of acetylcholine, GABA, and aspartate release from rat prefrontal cortex studied in vivo with microdialysis.
    Petkova-Kirova P; Rakovska A; Della Corte L; Zaekova G; Radomirov R; Mayer A
    Brain Res Bull; 2008 Sep; 77(2-3):129-35. PubMed ID: 18721670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel δ1-receptor agonist KNT-127 increases the release of dopamine and L-glutamate in the striatum, nucleus accumbens and median pre-frontal cortex.
    Tanahashi S; Ueda Y; Nakajima A; Yamamura S; Nagase H; Okada M
    Neuropharmacology; 2012 Apr; 62(5-6):2057-67. PubMed ID: 22266218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of NMDA-stimulated [14C]GABA and [3H]acetylcholine release by striatal glutamate and dopamine receptors.
    Hanania T; Johnson KM
    Brain Res; 1999 Oct; 844(1-2):106-17. PubMed ID: 10536266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glutamate receptor regulation of rat nucleus accumbens neurons in vivo.
    Hu XT; White FJ
    Synapse; 1996 Jul; 23(3):208-18. PubMed ID: 8807749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.